Skip to main navigation Skip to search Skip to main content

CTU: A PHASE 1/2, RANDOMIZED, DOUBLEMASKED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF AMG 732 IN HEALTHY SUBJECTS AND SUBJECTS WITH MODERATE-TO SEVERE ACUTE THYROID EYE DISEASE

  • Tumuluri, Krishna (Primary Chief Investigator)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Lawrie, Angus (Clinical Trial Unit Staff)
  • Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)

Project: Research

Project Details

Short title 20230302
AcronymAMG 732
StatusActive
Effective start/end date19/08/2518/07/26